Avails Medical Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Later Stage VC
- Investors
-
20
Avails Medical General Information
Description
Developer of an in vitro diagnostic technology designed to meet the global challenge of antibiotic resistance and health-care-associated infections. The company's technology is an electronic biosensor that improves accuracy in detecting infections and provides critical and timely information regarding antibiotic sensitivity and resistance, enabling laboratory technicians to use diagnostic-guided therapy at the point of care and reduce time-to-treatment.
Contact Information
Website
www.availsmedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
- 1455 Adams Drive
- Suite 1288
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Avails Medical Timeline
Avails Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-May-2023 | 000.00 | Completed | Generating Revenue | ||
| 8. Grant | 01-Sep-2022 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 7. Grant | 01-Jan-2021 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series B) | 01-Sep-2020 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 5. Debt - PPP | 30-Apr-2020 | 00000 | 00.000 | Completed | Generating Revenue | |
| 4. Early Stage VC (Series A) | 09-Feb-2017 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 3. Grant | 01-Jan-2016 | 00000 | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 25-Nov-2014 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jun-2014 | $75K | Completed | Generating Revenue |
Avails Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.00 |
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Avails Medical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of an in vitro diagnostic technology designed to meet the global challenge of antibiotic resistance and health
Diagnostic Equipment
Menlo Park, CA
35
As of 2023
000.00
0000000000 0
000.00
000000
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolor
0000000000 000000000
Rehovot, Israel
00
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
000000
um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000000000 000000000
Thousand Oaks, CA
00
As of 0000
000.00
00.00
0000-00-00
00000000
000.00
Add Comparison
Avails Medical Competitors (18)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nucleix | Venture Capital-Backed | Rehovot, Israel | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 00 | Formerly VC-backed | Thousand Oaks, CA | 00 | 000.00 | 00000000 | 000.00 |
| 000000 00000000 | Formerly VC-backed | San Francisco, CA | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 0000000000 | Venture Capital-Backed | Alameda, CA | 00 | 000.00 | 000000000 - | 000.00 |
| 0000000 | Venture Capital-Backed | Petaluma, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
Avails Medical Patents
Avails Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3171868-A1 | Devices, systems, and methods for measuring a solution characteristic of a sample using a multi-layered active sensor | Pending | 15-May-2020 | 000000000 | |
| EP-4150321-A2 | Devices, systems, and methods for measuring a solution characteristic of a sample using a multi-layered active sensor | Pending | 15-May-2020 | 000000000 | |
| US-20210371896-A1 | Devices, systems, and methods for preparing a standardized inoculum for antimicrobial susceptibility testing | Pending | 15-May-2020 | 000000000 | |
| US-D907795-S1 | Laboratory or medical reader | Active | 06-Jan-2020 | 0 | |
| CA-195116-S | Laboratory or medical reader | Active | 06-Jan-2020 |
Avails Medical Executive Team (7)
Avails Medical Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aaron Berez MD | Self | Board Member | 000 0000 |
| Matthew Cooper Ph.D | Self | Board Member | 000 0000 |
| Michael Laufer MD | Avails Medical | Board Member | 000 0000 |
| Nancy Isaac JD | Avails Medical | Co-Founder & Board Member | 000 0000 |
| Oren Knopfmacher Ph.D | Avails Medical | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Avails Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Avails Medical Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| MedVenture Partners (Japan) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CARB-X | University | 000 0000 | 000000 0 | ||
| Arrize Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Astia | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Caygan Capital | Hedge Fund | Minority | 000 0000 | 000000 0 |